AMAG PHARMACEUTICALS INC's ticker is AMAG and the CUSIP is 00163U106. A total of 178 filers reported holding AMAG PHARMACEUTICALS INC in Q2 2019. The put-call ratio across all filers is 1.11 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $110,000 | -91.4% | 17,927 | -86.0% | 0.01% | -76.0% |
| Q2 2019 | $1,282,000 | +504.7% | 128,375 | +678.2% | 0.05% | +316.7% |
| Q1 2019 | $212,000 | +16.5% | 16,497 | +37.5% | 0.01% | +33.3% |
| Q4 2018 | $182,000 | -90.9% | 12,000 | -86.5% | 0.01% | -70.0% |
| Q1 2017 | $1,997,000 | +662.2% | 88,600 | +728.0% | 0.03% | +233.3% |
| Q3 2016 | $262,000 | -48.3% | 10,700 | -50.7% | 0.01% | -64.0% |
| Q1 2016 | $507,000 | -38.0% | 21,700 | -19.9% | 0.02% | -50.0% |
| Q4 2015 | $818,000 | -69.5% | 27,100 | -59.9% | 0.05% | -75.2% |
| Q3 2015 | $2,685,000 | – | 67,600 | – | 0.20% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bleichroeder LP | 1,299,994 | $12,220,000 | 2.19% |
| Camber Capital Management LP | 8,780,000 | $82,532,000 | 2.18% |
| Palo Alto Investors LP | 3,003,875 | $28,236,000 | 1.55% |
| ARMISTICE CAPITAL, LLC | 4,120,000 | $38,728,000 | 1.40% |
| Permanens Capital L.P. | 359,311 | $3,378,000 | 1.17% |
| IRONWOOD INVESTMENT MANAGEMENT LLC | 31,582 | $297,000 | 0.21% |
| BOOTHBAY FUND MANAGEMENT, LLC | 348,000 | $3,271,000 | 0.20% |
| Teza Capital Management LLC | 20,300 | $191,000 | 0.11% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 767,135 | $7,211,000 | 0.08% |
| Livforsakringsbolaget Skandia, Omsesidigt | 38,800 | $365,000 | 0.04% |